Alyeska Investment Group, L.P. Day One Biopharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $1.47 Million - $1.81 Million	125,000 Added 47.14%	390,167 $4.66 Million
Q1 2023 May 15, 2023	BUY	$12.75 - $23.41 $1.55 Million - $2.85 Million	121,949 Added 85.15%	265,167 $3.55 Million
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $20,177 - $23,650	1,075 Added 0.76%	143,218 $3.08 Million
Q3 2022 Nov 14, 2022	SELL	$16.44 - $26.57 $1.23 Million - $1.99 Million	-75,000 Reduced 34.54%	142,143 $2.85 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $651,753 - $2.04 Million	113,943 Added 110.41%	217,143 $3.89 Million
Q2 2021 Aug 16, 2021	BUY	$19.0 - $23.69 $1.96 Million - $2.44 Million	103,200 New	103,200 $2.35 Million

178

84M

144K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.